Xin Lang Cai Jing·2026-01-05 11:40Core Viewpoint - The Chinese asset market is experiencing a strong start in 2026, with significant gains in both A-shares and Hong Kong stocks, driven by favorable monetary policies and sector-specific growth, particularly in pharmaceuticals and technology [1][24]. A-Share Market Summary - A-shares opened strongly, with the ChiNext Index rising by 2.85% and the Shanghai Composite Index surpassing 4000 points, achieving a record 12 consecutive days of gains, the longest streak since 1993, with trading volume exceeding 2.5 trillion yuan [1][24]. - The medical and healthcare sectors showed remarkable performance, with the Medical ETF (512170) increasing by 5.29%, marking its largest single-day gain since October 2024, and surpassing five key moving averages [4][26]. - The "AI twins" in the technology sector also performed well, with the Sci-Tech AI ETF (589520) rising by 4.74%, and the ChiNext AI ETF (159363) gaining over 3% to reach a new high since its listing [1][24]. Hong Kong Market Summary - The Hong Kong market also opened positively, with the Hang Seng Index rising by 2.76% and the Hang Seng Tech Index increasing by 4% on January 2, continuing to rise on January 5 [1][24]. - The Hong Kong Stock Connect Innovation Drug ETF (520880) surged by 5.42%, achieving its largest single-day gain since its launch in July 2025, with a trading volume of 5.09 billion yuan, reflecting a 263% increase from the previous day [4][28]. - The Hong Kong medical sector saw strong performance, particularly in the innovation drug segment, with 35 out of 37 covered stocks closing in the green, including notable gains from companies like InnoCare Pharma and Rongchang Bio [4][28]. Sector-Specific Insights - The brain-computer interface concept is gaining traction, with significant stock price increases in related companies, indicating a potential for substantial market growth in this area [6][28]. - The approval of 76 innovative drugs in China in 2025 set a historical record, with total transaction amounts exceeding 130 billion USD, highlighting the country's growing influence in the global pharmaceutical market [8][30]. - The technology sector, particularly in AI and semiconductor industries, is expected to continue its upward trajectory, supported by favorable policies and increasing foreign investment [1][24][15]. ETF Performance Overview - The Medical ETF (512170) recorded a trading volume of 11.66 billion yuan, a 211% increase from the previous trading day, reflecting strong investor interest in the healthcare sector [4][26]. - The Hong Kong Information Technology ETF (159131), focusing on the chip industry, rose by 3.63%, with a trading volume of 81.3 million yuan, indicating robust market activity in technology stocks [1][15]. Future Outlook - Analysts predict that the combination of domestic and international monetary policy easing will lead to continued net inflows of foreign and southbound capital, enhancing the profitability of Hong Kong-listed companies [1][24]. - The A-share market is expected to maintain its upward trend, driven by positive macroeconomic policies and a focus on technological innovation as a key driver for growth in 2026 [1][24].